Literature DB >> 23089055

Atrial septal defect closure with an Amplatzer septal occluder fenestrated with a coronary stent in a child with pulmonary arterial hypertension.

Gregory J Skinner1, Robert M Tulloh, Andrew J Tometzki, Ingram Schulze-Neick, Gareth J Morgan.   

Abstract

The presence of an atrial septal defect in pulmonary hypertension has benefits and detractions. Even in idiopathic pulmonary arterial hypertension, a significant left-to-right shunt at atrial level may increase the pulmonary arterial pressure and exacerbate the disease. However, it is well recognised that the presence of an atrial communication may be protective in subgroups with severe disease, allowing maintenance of cardiac output during times of increased pulmonary resistance. In the present paper, we present the case of a young boy with significant idiopathic pulmonary arterial hypertension and an atrial septal defect. We report our technique of septal occlusion using a device to decrease left-to-right shunting with concomitant stent insertion in that device to maintain the potential for right-to-left shunting during times of high pulmonary arterial pressure.

Entities:  

Mesh:

Year:  2012        PMID: 23089055     DOI: 10.1017/S1047951112001771

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  2 in total

1.  Atrial Septal Defect Closure with Occlutech® ASD Fenestrated Device in a Child with Severe Pulmonary Hypertension.

Authors:  Francisco Gonzalez-Barlatay; Anne Fournier; Marie-Josée Raboisson; Nagib Dahdah
Journal:  Pediatr Cardiol       Date:  2016-11-21       Impact factor: 1.655

2.  A novel method of creation of a fenestration in nitinol occluder devices used in closure of hypertensive patent arterial ducts.

Authors:  Anil Kumar Singhi; Kothandam Sivakumar
Journal:  Ann Pediatr Cardiol       Date:  2016 Jan-Apr
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.